The Benefits of Having One Good Risk Molecular Marker for Ring Sitter a Blast

There's only one good risk molecular marker and that's s s f B 31, and that is associated with ring sitter a blast. Everything else is intermediate or poor so that includes TP 53 easy L 12 TV six Ron XOne you may recognize some of these from a m l poor risk criteria. So do all MDS patients require treatment? No if you have good or very good features some patients can be observed. If they fall into all these categories you don't actually need to treat them right away.